top of page


PharmaLogic agrees to acquire Lantheus radiopharmaceutical CDMO business and New Jersey manufacturing facility
PharmaLogic has signed a definitive agreement to acquire Lantheus' radiopharmaceutical CDMO operations and Springfield manufacturing facility, expanding specialist production capabilities for therapeutic radiopharmaceuticals.

nuaxia
39 minutes ago2 min read


FDA grants final approval to Bravnetsa for SSTR-positive GEP-NETs
The FDA has granted final approval to Lantheus' Bravnetsa for adults with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours.

nuaxia
Sep 231 min read
bottom of page